{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:22:26Z","timestamp":1770456146271,"version":"3.49.0"},"reference-count":85,"publisher":"Bentham Science Publishers Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHR"],"published-print":{"date-parts":[[2019,10,23]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Non-alcoholic Fatty Liver Disease (NAFLD) is common in HIV-infected\nindividuals. Liver biopsy remains the gold-standard procedure for the diagnosis of liver fibrosis, but\nboth Transient Elastography (TE) and Non-invasive Biomarkers (NIBMs) have emerged as alternatives.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>Our study\u2019s aim was to validate commonly used NIBMs for the assessment of liver fibrosis\nin a cohort of Greek HIV-mono-infected patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Inclusion criteria were confirmed HIV-infection and age&gt;18 years and exclusion criteria\nHBV or HCV seropositivity, liver disease other than NAFLD, alcohol abuse, ascites, transaminases\nlevels&gt;4xULN(upper limit of normal) and Body-Mass index(BMI)&gt;40. Liver stiffness (LS) measurement\nwith TE and thorough laboratory work up and medical history were acquired at study entry.\nFIB-4, APRI, NFS, BARD, Forns and Lok scores were calculated for each patient.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 157 patients were eligible for this study. Significant liver fibrosis, compatible\nwith Metavir score of F3-F4, was found in only 11(7%) patients. These findings were in accordance\nwith those of the NIBMs; the BARD score constituting the only exception, allocating 102(65%) patients\nas having significant liver fibrosis. In order to obtain a balance between sensitivity and specificity\nnew cut-offs for each NIBM were calculated; FIB-4 score yielded the best results, since by\nchanging the cut-off to 1.49 a sensitivity and specificity balanced for both close to 85% was\nachieved.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>Our findings suggest that NIBMs can be used for the evaluation of liver fibrosis in HIV\nmono-infected patients. New cut-offs for NIBMs should probably be calculated, to help distinguishing\npatients with significant from those with mild\/no fibrosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570162x17666190809153245","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T03:17:20Z","timestamp":1569295040000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Liver Fibrosis Assessment in a Cohort of Greek HIV Mono-Infected Patients by Non-Invasive Biomarkers"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-6230","authenticated-orcid":true,"given":"Theodoros","family":"Androutsakos","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7371-1685","authenticated-orcid":true,"given":"Maria","family":"Schina","sequence":"additional","affiliation":[{"name":"Liver unit, Euroclinic of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-3619","authenticated-orcid":true,"given":"Abraham","family":"Pouliakis","sequence":"additional","affiliation":[{"name":"Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Kontos","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Laiko General Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-3453","authenticated-orcid":true,"given":"Nikolaos","family":"Sipsas","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorios","family":"Hatzis","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"S5-57","volume":"15","author":"Mayor AM","year":"2005","unstructured":"Mayor AM; G\u00f3mez MA; R\u00edos-Oliveras E; Hunter-Mellado RF; Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: Analysis of a cohort of 3,322 HIV-infected persons. Ethn Dis 2005,15(4 Suppl 5),S5-57-62","journal-title":"Ethn Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","year":"2008","unstructured":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet Antiretroviral Therapy Cohort Collaboration2008,372(9635),293-299","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1111\/j.1365-3156.2012.02841.x","volume":"17","author":"Kasamba I.","year":"2012","unstructured":"Kasamba I.; Baisley K.; Mayanja B.N.; Maher D.; Grosskurth H.; The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: A longitudinal population-based study, 1999-2009. Trop Med Int Health 2012,17(8),e66-e73","journal-title":"Trop Med Int Health"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"22789","DOI":"10.3402\/gha.v7.22789","volume":"7","author":"Slaymaker E.","year":"2014","unstructured":"Slaymaker E.; Todd J.; Marston M.; How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa. Glob Health Action 2014,7,22789","journal-title":"Glob Health Action"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S533","DOI":"10.1097\/QAD.0000000000000496","volume":"28","author":"Reniers G.","year":"2014","unstructured":"Reniers G.; Slaymaker E.; Nakiyingi-Miiro J.; ALPHA Network. Mortality trends in the era of antiretroviral therapy: Evidence from the Network for Analysing Longitudinal Population based HIV\/AIDS data on Africa (ALPHA). AIDS 2014,28(Suppl. 4),S533-S542","journal-title":"AIDS"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12879-017-2254-7","volume":"17","author":"Eyawo O.","year":"2017","unstructured":"Eyawo O.; Franco-Villalobos C.; Hull M.W.; Comparative Outcomes And Service Utilization Trends (COAST) study. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012. BMC Infect Dis 2017,17(1),174","journal-title":"BMC Infect Dis"},{"key":"ref=7","first-page":"1","volume":"86","author":"Cappell M.S.","year":"1991","unstructured":"Cappell M.S.; Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastroenterol 1991,86(1),1-15","journal-title":"Am J Gastroenterol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000171468","volume":"12","author":"Lefkowitch J.H.","year":"1994","unstructured":"Lefkowitch J.H.; Pathology of AIDS-related liver disease. Dig Dis 1994,12(6),321-330","journal-title":"Dig Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2005.01.022","volume":"42","author":"Salmon-Ceron D.","year":"2005","unstructured":"Salmon-Ceron D.; Lewden C.; Morlat P.; Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol Mortality 2000 study group2005,42(6),799-805","journal-title":"J Hepatol"},{"key":"ref=10","first-page":"197","volume":"7","author":"Piroth L.","year":"2005","unstructured":"Piroth L.; Liver steatosis in HIV-infected patients. AIDS Rev 2005,7(4),197-209","journal-title":"AIDS Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12664-016-0666-8","volume":"35","author":"Puri P.","year":"2016","unstructured":"Puri P.; Kumar S.; Liver involvement in human immunodeficiency virus infection. Indian J Gastroenterol 2016,35(4),260-273","journal-title":"Indian J Gastroenterol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12664-016-0676-6","volume":"35","author":"Shamanna S.B.","year":"2016","unstructured":"Shamanna S.B.; Naik R.R.; Hamide A.; Causes of liver disease and its outcome in HIV-infected individuals. Indian J Gastroenterol 2016,35(4),310-314","journal-title":"Indian J Gastroenterol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"Ratziu V.","year":"2010","unstructured":"Ratziu V.; Bellentani S.; Cortez-Pinto H.; Day C.; Marchesini G.; A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J Hepatol 2010,53(2),372-384","journal-title":"J Hepatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"Byrne C.D.","year":"2015","unstructured":"Byrne C.D.; Targher G.; NAFLD: a multisystem disease. J Hepatol 2015,62(Suppl. 1),S47-S64","journal-title":"J Hepatol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"Sayiner M.","year":"2016","unstructured":"Sayiner M.; Koenig A.; Henry L.; Younossi Z.M.; Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis 2016,20(2),205-214","journal-title":"Clin Liver Dis"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050774","volume":"17","author":"Calzadilla Bertot L.","year":"2016","unstructured":"Calzadilla Bertot L.; Adams L.A.; The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2016,17(5)","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"Fan J.G.","year":"2017","unstructured":"Fan J.G.; Kim S.U.; Wong V.W.; New trends on obesity and NAFLD in Asia. J Hepatol 2017,67(4),862-873","journal-title":"J Hepatol"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140908","volume":"10","author":"Anderson E.L.","year":"2015","unstructured":"Anderson E.L.; Howe L.D.; Jones H.E.; Higgins J.P.; Lawlor D.A.; Fraser A.; The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS One 2015,10(10)","journal-title":"PLoS One"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/liv.13299","volume":"37","author":"Bellentani S.","year":"2017","unstructured":"Bellentani S.; The epidemiology of non-alcoholic fatty liver disease. Liver Int 2017,37(Suppl. 1),81-84","journal-title":"Liver Int"},{"key":"ref=20","first-page":"S0168","author":"Haldar D.","year":"2019","unstructured":"Haldar D.; Kern B.; Hodson J.; Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry Study. J Hepatol 2019,S0168-S8278","journal-title":"J Hepatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/lt.25387","volume":"25","author":"Sayiner M.","year":"2019","unstructured":"Sayiner M.; Younossi Z.M.; Nonalcoholic Steatohepatitis Is Becoming a Top Indication for Liver Transplantation Worldwide. Liver Transpl 2019,25(1),10-11","journal-title":"Liver Transpl"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.aids.0000206503.01536.11","volume":"20","author":"Lemoine M.","year":"2006","unstructured":"Lemoine M.; Barbu V.; Girard P.M.; Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients. AIDS 2006,20(3),387-395","journal-title":"AIDS"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cgh.2009.09.025","volume":"8","author":"Crum-Cianflone N.","year":"2010","unstructured":"Crum-Cianflone N.; Collins G.; Medina S.; Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons. Clin Gastroenterol Hepatol 2010,8(2),183-191","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.7326\/0003-4819-158-9-201305070-00604","volume":"158","author":"Kirk G.D.","year":"2013","unstructured":"Kirk G.D.; Mehta S.H.; Astemborski J.; HIV, age, and the severity of hepatitis C virus-related liver disease: A cohort study. Ann Intern Med 2013,158(9),658-666","journal-title":"Ann Intern Med"},{"key":"ref=25","first-page":"35","volume":"19","author":"Mac\u00edas J.","year":"2017","unstructured":"Mac\u00edas J.; Pineda J.A.; Real L.M.; Non-Alcoholic Fatty Liver Disease in HIV Infection. AIDS Rev 2017,19(1),35-46","journal-title":"AIDS Rev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11904-017-0351-2","volume":"14","author":"Rockstroh J.K.","year":"2017","unstructured":"Rockstroh J.K.; Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV. Curr HIV\/AIDS Rep 2017,14(2),47-53","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra041811","volume":"352","author":"Grinspoon S.","year":"2005","unstructured":"Grinspoon S.; Carr A.; Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005,352(1),48-62","journal-title":"N Engl J Med"},{"key":"ref=28","first-page":"1045","volume":"74","author":"Grunfeld C.","year":"1992","unstructured":"Grunfeld C.; Pang M.; Doerrler W.; Shigenaga J.K.; Jensen P.; Feingold K.R.; Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992,74(5),1045-1052","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/00365540310004054","volume":"35","author":"Sipsas N.V.","year":"2003","unstructured":"Sipsas N.V.; Kosmas N.; Kontos A.; Eftychiadis C.; Agapitos E.; Kordossis T.; Fatal Nucleoside-Associated Lactic Acidosis in a Human Immunodeficiency Virus Type-1 Infected Obese Woman, Following a Very-Low-Calorie Diet. Scand J Infect Dis 2003,35,291-293","journal-title":"Scand J Infect Dis"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","year":"1994","unstructured":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology The French METAVIR Cooperative Study Group1994,20(1 Pt 1),15-20","journal-title":"Hepatology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"Ratziu V.","year":"2005","unstructured":"Ratziu V.; Charlotte F.; Heurtier A.; Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology LIDO Study Group2005,128(7),1898-1906","journal-title":"Gastroenterology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","volume":"8","author":"Seeff L.B.","year":"2010","unstructured":"Seeff L.B.; Everson G.T.; Morgan T.R.; Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol HALT\u2013C Trial Group2010,8(10),877-883","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","volume":"2","author":"Piccinino F.","year":"1986","unstructured":"Piccinino F.; Sagnelli E.; Pasquale G.; Giusti G.; Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986,2(2),165-173","journal-title":"J Hepatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2893.2009.01210.x","volume":"17","author":"Cross T.J.","year":"2010","unstructured":"Cross T.J.; Calvaruso V.; Maimone S.; Prospective comparison of Fibroscan, King\u2019s score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J Viral Hepat 2010,17(8),546-554","journal-title":"J Viral Hepat"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010542.pub2","author":"Pavlov CS","year":"2015","unstructured":"Pavlov CS; Casazza G; Nikolova D; Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev 2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28394","volume":"63","author":"Cassinotto C.","year":"2016","unstructured":"Cassinotto C.; Boursier J.; de L\u00e9dinghen V.; Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 2016,63(6),1817-1827","journal-title":"Hepatology"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.6061\/clinics\/2017(09)01","volume":"72","author":"Ragazzo T.G.","year":"2017","unstructured":"Ragazzo T.G.; Paranagua-Vezozzo D.; Lima F.R.; Accuracy of transient elastography-FibroScan\u00ae, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C. Clinics (S\u00e3o Paulo) 2017,72(9),516-525","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12072-018-9843-4","volume":"12","author":"Kamarajah S.K.","year":"2018","unstructured":"Kamarajah S.K.; Chan W.K.; Nik Mustapha N.R.; Mahadeva S.; Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. Hepatol Int 2018,12(1),44-55","journal-title":"Hepatol Int"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"Eddowes P.J.","year":"2019","unstructured":"Eddowes P.J.; Sasso M.; Allison M.; Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2019,156(6),1717-1730","journal-title":"Gastroenterology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4292\/wjgpt.v7.i1.91","volume":"7","author":"Chang P.E.","year":"2016","unstructured":"Chang P.E.; Goh G.B.; Ngu J.H.; Tan H.K.; Tan C.K.; Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J Gastrointest Pharmacol Ther 2016,7(1),91-106","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/hep.23425","volume":"51","author":"Cast\u00e9ra L.","year":"2010","unstructured":"Cast\u00e9ra L.; Foucher J.; Bernard P.H.; Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010,51(3),828-835","journal-title":"Hepatology"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"Vallet-Pichard A.","year":"2007","unstructured":"Vallet-Pichard A.; Mallet V.; Nalpas B.; FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007,46(1),32-36","journal-title":"Hepatology"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"Angulo P.","year":"2007","unstructured":"Angulo P.; Hui J.M.; Marchesini G.; The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007,45(4),846-854","journal-title":"Hepatology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-230X-10-67","volume":"10","author":"Raszeja-Wyszomirska J.","year":"2010","unstructured":"Raszeja-Wyszomirska J.; Szymanik B.; \u0141awniczak M.; Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol 2010,10,67","journal-title":"BMC Gastroenterol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"Wai C.T.","year":"2003","unstructured":"Wai C.T.; Greenson J.K.; Fontana R.J.; A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003,38(2),518-526","journal-title":"Hepatology"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"Lin Z.H.","year":"2011","unstructured":"Lin Z.H.; Xin Y.N.; Dong Q.J.; Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011,53(3),726-736","journal-title":"Hepatology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/hep.24013","volume":"53","author":"Mart\u00ednez S.M.","year":"2011","unstructured":"Mart\u00ednez S.M.; Crespo G.; Navasa M.; Forns X.; Noninvasive assessment of liver fibrosis. Hepatology 2011,53(1),325-335","journal-title":"Hepatology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.20772","volume":"42","author":"Lok A.S.","year":"2005","unstructured":"Lok A.S.; Ghany M.G.; Goodman Z.D.; Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005,42(2),282-292","journal-title":"Hepatology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/jhep.2002.36128","volume":"36","author":"Forns X.","year":"2002","unstructured":"Forns X.; Ampurdan\u00e8s S.; Llovet J.M.; Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002,36(4 Pt 1),986-992","journal-title":"Hepatology"},{"key":"ref=50","year":"2005","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Helping\npatients who drink too much:  A clinician\u2019s guide NIH Publication no. 05-3769, Bethesda, MD.2005","journal-title":"A clinician\u2019s guide NIH"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"Sandrin L.","year":"2003","unstructured":"Sandrin L.; Fourquet B.; Hasquenoph J.M.; Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003,29(12),1705-1713","journal-title":"Ultrasound Med Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","volume":"48","author":"Castera L.","year":"2008","unstructured":"Castera L.; Forns X.; Alberti A.; Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008,48(5),835-847","journal-title":"J Hepatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1080\/00949655.2013.766189","volume":"84","author":"Marozzi M.","year":"2014","unstructured":"Marozzi M.; Testing for concordance between several criteria. J Stat Comput Simul 2014,84(9),1843-1850","journal-title":"J Stat Comput Simul"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s10815-019-01498-7","volume":"36","author":"Vogiatzi P.","year":"2019","unstructured":"Vogiatzi P.; Pouliakis A.; Siristatidis C.; An artificial neural network for the prediction of assisted reproduction outcome. J Assist Reprod Genet 2019,36(7),1441-1448","journal-title":"J Assist Reprod Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/dc.23649","volume":"45","author":"Makris G.M.","year":"2017","unstructured":"Makris G.M.; Pouliakis A.; Siristatidis C.; Image analysis and multi-layer perceptron artificial neural networks for the discrimination between benign and malignant endometrial lesions. Diagn Cytopathol 2017,45(3),202-211","journal-title":"Diagn Cytopathol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/infdis\/jiw645","volume":"215","author":"Kottaridi C.","year":"2017","unstructured":"Kottaridi C.; Kyrgiou M.; Pouliakis A.; Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease. J Infect Dis 2017,215(5),764-771","journal-title":"J Infect Dis"},{"key":"ref=57","first-page":"189","volume":"36","author":"Zygouris D.","year":"2014","unstructured":"Zygouris D.; Pouliakis A.; Margari N.; Classification of endometrial lesions by nuclear morphometry features extracted from liquid-based cytology samples: a system based on logistic regression model. Anal Quant Cytopathol Histpathol 2014,36(4),189-198","journal-title":"Anal Quant Cytopathol Histpathol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.1365-2036.2011.04861.x","volume":"34","author":"Sebastiani G.","year":"2011","unstructured":"Sebastiani G.; Castera L.; Halfon P.; The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011,34(10),1202-1216","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=59","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104553","volume":"169","author":"Charre C.","year":"2019","unstructured":"Charre C.; Levrero M.; Zoulim F.; Scholt\u00e8s C.; Non-invasive biomarkers for chronic hepatitis B virus infection management. Antiviral Res 2019,169","journal-title":"Antiviral Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/17474124.2019.1579641","volume":"13","author":"Agbim U.","year":"2019","unstructured":"Agbim U.; Asrani S.K.; Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Rev Gastroenterol Hepatol 2019,13(4),361-374","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/00002030-200303280-00010","volume":"17","author":"Myers R.P.","year":"2003","unstructured":"Myers R.P.; Benhamou Y.; Imbert-Bismut F.; Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 2003,17(5),721-725","journal-title":"AIDS"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gut.2005.065904","volume":"55","author":"Mac\u00edas J.","year":"2006","unstructured":"Mac\u00edas J.; Gir\u00f3n-Gonz\u00e1lez J.A.; Gonz\u00e1lez-Serrano M.; Prediction of liver fibrosis in human immunodeficiency virus\/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 2006,55(3),409-414","journal-title":"Gut"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/QAI.0b013e318030ff8e","volume":"44","author":"Al-Mohri H.","year":"2007","unstructured":"Al-Mohri H.; Murphy T.; Lu Y.; Lalonde R.G.; Klein M.B.; Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr 2007,44(4),463-469","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jhep.2008.01.025","volume":"48","author":"Cacoub P.","year":"2008","unstructured":"Cacoub P.; Carrat F.; B\u00e9dossa P.; Comparison of non-invasive liver fibrosis biomarkers in HIV\/HCV co-infected patients: the fibrovic study--ANRS HC02. J Hepatol 2008,48(5),765-773","journal-title":"J Hepatol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cca.2008.07.009","volume":"397","author":"Trang T.","year":"2008","unstructured":"Trang T.; Petersen J.R.; Snyder N.; Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: Comparison of the APRI and FIB-4 index. Clin Chim Acta 2008,397(1-2),51-54","journal-title":"Clin Chim Acta"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/157340608786242052","volume":"4","author":"Bongiovanni M.","year":"2008","unstructured":"Bongiovanni M.; Casana M.; Non-invasive markers of liver fibrosis in HCV mono-infected and in HIV\/HCV co-infected subjects. Med Chem 2008,4(6),513-519","journal-title":"Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2174\/157016211796320298","volume":"9","author":"Sanvisens A.","year":"2011","unstructured":"Sanvisens A.; Fuster D.; Serra I.; Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV\/HIV-coinfected drug users. Curr HIV Res 2011,9(4),256-262","journal-title":"Curr HIV Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1365-2036.2010.04560.x","volume":"33","author":"Singal A.G.","year":"2011","unstructured":"Singal A.G.; Thomassen L.V.; Gretch D.R.; Shuhart M.C.; Use of the AST to platelet ratio index in HCV\/HIV co-infected patients. Aliment Pharmacol Ther 2011,33(5),566-577","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3851\/IMP2686","volume":"19","author":"Rohrbach J.","year":"2014","unstructured":"Rohrbach J.; Stickel F.; Schmid P.; Swiss HIV Cohort Study. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals. Antivir Ther (Lond) 2014,19(2),149-159","journal-title":"Antivir Ther (Lond)"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138838","volume":"10","author":"Schmid P.","year":"2015","unstructured":"Schmid P.; Bregenzer A.; Huber M.; Swiss HIV Cohort Study. Progression of Liver Fibrosis in HIV\/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy. PLoS One 2015,10(9)","journal-title":"PLoS One"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jhep.2009.01.022","volume":"50","author":"Bottero J.","year":"2009","unstructured":"Bottero J.; Lacombe K.; Gu\u00e9chot J.; Performance of 11 biomarkers for liver fibrosis assessment in HIV\/HBV co-infected patients. J Hepatol 2009,50(6),1074-1083","journal-title":"J Hepatol"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5629130","volume":"2017","author":"Kilonzo S.B.","year":"2017","unstructured":"Kilonzo S.B.; Gunda D.W.; Kashasha F.; Mpondo B.C.; Liver Fibrosis and Hepatitis B Coinfection among ART Na\u00efve HIV-Infected Patients at a Tertiary Level Hospital in Northwestern Tanzania: A Cross-Sectional Study. J Trop Med 2017,2017","journal-title":"J Trop Med"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30825","author":"Sterling R.K.","year":"2019","unstructured":"Sterling R.K.; King W.C.; Wahed A.S.; HIV-HBV Cohort Study of the Hepatitis B Research Network. Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV\/HIV coinfected adults. Hepatology [Epub Ahead of Print]2019","journal-title":"Hepatology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2334-10-116","volume":"10","author":"DallaPiazza M.","year":"2010","unstructured":"DallaPiazza M.; Amorosa VK.; Localio R.; Kostman JR.; Lo Re V III.; Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients. BMC Infect Dis 2010,10,116","journal-title":"BMC Infect Dis"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/cid\/ciq199","volume":"52","author":"Blackard J.T.","year":"2011","unstructured":"Blackard J.T.; Welge J.A.; Taylor L.E.; HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis 2011,52(5),674-680","journal-title":"Clin Infect Dis"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/cid\/cir071","volume":"52","author":"Mendeni M.","year":"2011","unstructured":"Mendeni M.; Foc\u00e0 E.; Gotti D.; Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis 2011,52(9),1164-1173","journal-title":"Clin Infect Dis"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/infdis\/jir885","volume":"205","author":"Price J.C.","year":"2012","unstructured":"Price J.C.; Seaberg E.C.; Badri S.; Witt M.D.; D\u2019Acunto K.; Thio C.L.; HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis 2012,205(6),1005-1013","journal-title":"J Infect Dis"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/liv.12159","volume":"33","author":"Hasson H.","year":"2013","unstructured":"Hasson H.; Merli M.; Galli L.; Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs. Liver Int 2013,33(7),1113-1120","journal-title":"Liver Int"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4254\/wjh.v5.i10.584","volume":"5","author":"Tahiri M.","year":"2013","unstructured":"Tahiri M.; Sodqi M.; Lahdami F.E.; Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco. World J Hepatol 2013,5(10),584-588","journal-title":"World J Hepatol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/cid\/civ101","volume":"60","author":"Morse C.G.","year":"2015","unstructured":"Morse C.G.; McLaughlin M.; Matthews L.; Nonalcoholic steatohepatitis and hepatic fibrosis in HIV-1-monoinfected adults with elevated aminotransferase levels on antiretroviral therapy. Clin Infect Dis 2015,60(10),1569-1578","journal-title":"Clin Infect Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11904-016-0329-5","volume":"13","author":"Matta B.","year":"2016","unstructured":"Matta B.; Lee T.H.; Patel K.; Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. Curr HIV\/AIDS Rep 2016,13(5),279-288","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.3748\/wjg.14.6154","volume":"14","author":"Oliveri F.","year":"2008","unstructured":"Oliveri F.; Coco B.; Ciccorossi P.; Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol 2008,14(40),6154-6162","journal-title":"World J Gastroenterol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/gut.2008.149708","volume":"57","author":"Arena U.","year":"2008","unstructured":"Arena U.; Vizzutti F.; Abraldes J.G.; Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008,57(9),1288-1293","journal-title":"Gut"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/MCG.0b013e3181b4af1f","volume":"44","author":"Stebbing J.","year":"2010","unstructured":"Stebbing J.; Farouk L.; Panos G.; A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010,44(3),214-219","journal-title":"J Clin Gastroenterol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhep.2010.06.022","volume":"54","author":"Gaia S.","year":"2011","unstructured":"Gaia S.; Carenzi S.; Barilli A.L.; Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011,54(1),64-71","journal-title":"J Hepatol"}],"container-title":["Current HIV Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T09:24:05Z","timestamp":1574241845000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174240\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,10,23]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570162x17666190809153245","relation":{},"ISSN":["1570-162X"],"issn-type":[{"value":"1570-162X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}